Antifungal agents--clinical pharmacokinetics and drug interactions.
about
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14α-Demethylase.Voriconazole pharmacokinetics in liver transplant recipients.Pharmacokinetics of antifungal agents in children.Interactions between antifungal and antiretroviral agents.Opportunistic invasive fungal infections: diagnosis & clinical management.Invasive Candida infections in solid organ transplant recipient children.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.[Strategies for antifungal treatment failure in intensive care units].Candida infections in solid organ transplantation.Clinical pharmacodynamics and pharmacokinetics of the antifungal extended-spectrum triazole posaconazole: an overview.Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysis.Activity of 3'-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models.Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America.Single-dose pharmacokinetics of ceftazidime and fluconazole during concurrent clinical use in cold-stunned Kemp’s ridley turtles (Lepidochelys kempii)Synthesis and Biological Activity of Sterol 14α-Demethylase and Sterol C24-Methyltransferase Inhibitors
P2860
Q27324352-239C0FEE-FA6B-462F-A7DC-79C4067A15B3Q33613685-43C77F1E-52B9-4DA8-9D50-CD2190FB6A1EQ36163345-61FC84CC-54BE-440E-B0D1-6EBF40F6D1F7Q37719545-51CDDB64-FDF9-476A-B100-C3B39A2A9AABQ37726198-9860EC31-147B-486E-8AB8-2B34E6B42C8FQ37854722-3C7EBFB3-CB1F-4252-8120-9F3F35230F6BQ37918556-16E3FB45-663C-4B9F-AD9F-F56B251B5F30Q40746038-3FB2B71F-20C0-490C-B18D-B5D0DA8D34A1Q40982014-00C6CF40-C1FF-4168-8BA3-6607AA2A132CQ41010354-835D4D26-AD98-43B2-9C07-EE6DDDDD2883Q42272295-84E82DDA-E55D-4986-920C-8593792B03DDQ42413286-B2DE7F31-67F1-4C3F-8FD0-28E347B7122FQ43233993-239A1C4A-7938-49AE-A91B-31B9EE596E83Q44334907-F7B586CB-E737-47AA-8D5E-FA4BFC8BC67AQ47700700-51F578B9-0986-423B-AFF5-036B05861227Q47963266-B4D76577-201D-4ECC-AEE1-E6A1DD6355B7Q51617424-2466D7DA-4AB6-4E8A-9FD7-3CE525BE0649Q57432721-92FA5A23-F86B-4C59-ACA6-DB0191637711Q58842234-2A953DFA-6903-4755-A243-43592492445B
P2860
Antifungal agents--clinical pharmacokinetics and drug interactions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifungal agents--clinical pharmacokinetics and drug interactions.
@en
Antifungal agents--clinical pharmacokinetics and drug interactions.
@nl
type
label
Antifungal agents--clinical pharmacokinetics and drug interactions.
@en
Antifungal agents--clinical pharmacokinetics and drug interactions.
@nl
prefLabel
Antifungal agents--clinical pharmacokinetics and drug interactions.
@en
Antifungal agents--clinical pharmacokinetics and drug interactions.
@nl
P2860
P1433
P1476
Antifungal agents--clinical pharmacokinetics and drug interactions.
@en
P2860
P356
10.1111/J.1439-0507.2008.01523.X
P478
51 Suppl 1
P577
2008-01-01T00:00:00Z